Genenta Science SPA - ADRGNTA
13F holders, Q1 2025 (March 31)5holders +1
2new positions
1sold out
$3.92avg. 13F price*
At the end of Q1 2025, 5 institutions reported holding Genenta Science SPA - ADR (GNTA) in their 13F filings, up 1 from Q4 2024. 2 opened new positions and 1 sold out. The largest holders were Allianz SE ($927K), AlTi Global, Inc. ($795K) and Algebris (uk) Ltd. ($368K).
- Company
- Genenta Science SPA - ADR
- CUSIP
- 36870W100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $14K |
| Exits | 1 | $46K |
All 13F filers, Q4 2024 → Q1 2025: 188,791 shares bought and 11,167 shares sold, net +177,624 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Allianz SE | 0.02% | Add +126.2% | 233,550 | $927K |
| AlTi Global, Inc. | 0.02% | No change | 200,288 | $795K |
| Algebris (uk) Ltd. | 0.07% | Add +122.2% | 100,000 | $368K |
| Morgan Stanley | 0.00% | New | 3,400 | $13K |
| UBS Group AG | 0.00% | New | 91 | $361 |
"% of holder's portfolio" is GNTA's weight in each manager's 13F, not the share of Genenta Science SPA - ADR the manager owns.